Suppr超能文献

新型促胃肠动力剂KW-5092对大鼠结肠推进延迟的影响。

Effects of KW-5092, a novel gastroprokinetic agent, on the delayed colonic propulsion in rats.

作者信息

Takasaki K, Kishibayashi N, Ishii A, Karasawa A

机构信息

Department of Pharmacology, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.

出版信息

Jpn J Pharmacol. 1994 May;65(1):67-71. doi: 10.1254/jjp.65.67.

Abstract

The effects of KW-5092, [1-[2-[[[5-(piperidinomethyl)-2- furanyl]methyl]amino]ethyl]-2-imidazolidinylidene]propanedinitr ile fumarate, on the loperamide- or clonidine-induced delayed propulsion were determined in rats and compared with those of other gastroprokinetic agents. Administration of loperamide (0.3 mg/kg, s.c.) or clonidine (0.01 mg/kg, s.c.) induced delay of the evacuation time of the teflon ball, which had been inserted into the distal colon. The delayed evacuation was improved dose-dependently by KW-5092 at 3 to 10 mg/kg (p.o.) or higher. Neostigmine at 0.3 to 3 mg/kg (p.o.) and T-1815 at 1 to 100 mg/kg (p.o.) also improved the delayed ball evacuation. These results suggest that KW-5092 stimulates the delayed colonic propulsion.

摘要

在大鼠中测定了富马酸[1-[2-[[[5-(哌啶甲基)-2-呋喃基]甲基]氨基]乙基]-2-咪唑烷亚基]丙二腈(KW-5092)对洛哌丁胺或可乐定诱导的延迟推进作用,并与其他胃肠促动力剂进行了比较。皮下注射洛哌丁胺(0.3mg/kg)或可乐定(0.01mg/kg)会导致插入远端结肠的聚四氟乙烯球排空时间延迟。KW-5092以3至10mg/kg(口服)或更高剂量可剂量依赖性地改善延迟排空。口服新斯的明(0.3至3mg/kg)和T-1815(1至100mg/kg)也可改善球排空延迟。这些结果表明KW-5092可刺激延迟的结肠推进。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验